This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Versitech, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Chi Hang Lui: Innovator in Diagnostic Methods for Biliary Atresia
Introduction
Chi Hang Lui is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of medical diagnostics, particularly in relation to biliary atresia. His innovative work has led to the development of novel methods that enhance the diagnosis and prognosis of this condition.
Latest Patents
Chi Hang Lui holds a patent titled "Amyloid precursor protein as a diagnostic marker for biliary atresia." This patent provides groundbreaking diagnostic and prognostic methods utilizing amyloid precursor protein, which can significantly improve the detection and management of biliary atresia. He has 1 patent to his name.
Career Highlights
Chi Hang Lui is associated with Versitech, Inc., where he continues to advance his research and innovations. His work is characterized by a commitment to improving healthcare outcomes through scientific discovery and technological advancement.
Collaborations
Chi Hang Lui has collaborated with notable colleagues, including Rosana Ottakandathil Babu and Paul Kwong Hang Tam. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs in their field.
Conclusion
Chi Hang Lui's contributions to the field of diagnostics, particularly for biliary atresia, underscore his role as a key innovator. His work not only reflects his expertise but also his dedication to improving patient care through innovative solutions.